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Abstract
Background: Despite limitations of routine methods, Clinical Practice Guidelines support the assessment of bone
mineral density (BMD) and vascular calcification in renal transplant recipients. Changes in fat mass also occur
post-transplantation, although they are traditionally difficult to measure accurately. We report the feasibility,
convenience and accuracy of measuring the above 3 parameters using a novel CT protocol.
Methods: We conducted a cross-sectional study of 64 first renal allograft recipients (eGFR > 30 ml/min/1.73 m2).
Quantitative CT (QCT) BMD analysis was conducted using CT lumbar spine (GE Medical Systems Lightspeed VCT &
Mindways QCT Pro Bone Mineral Densitometry System Version 4.2.3) to calculate spinal volumetric BMD and
compared with standard DXA calculated areal BMD at the spine, hip and distal forearm. Abdominal aortic
calcification was assessed by semi-quantitative Aortic Calcification Index (ACI) method and compared with lateral
lumbar x-ray Kappuila score and pulse wave velocity (PWV). Visceral and subcutaneous adipose tissue volume
(Osirix 16 Ver 3.7.1) was compared with BMI.
Results: Participants were 61 % male, had a mean age of 47 years, median ESKD duration of 5.4 years and a mean
eGFR of 54 ml/min. iDXA median T-score at proximal femur was −1.2 and at lumbar spine was −0.2. Median QCT
Trabecular T-score at lumbar spine was −1.2. The percent of subjects with a T-score of <2.5 by site and method was
DXA Proximal Femur: 7 %, DXA distal radius: 17 %, DXA spine: 9 %, QCT (American College of Radiology cutoffs):
9 %. CT derived ACI correlated with PWV (r = 0.29, p = 0.02), pulse wave pressure (r = 0.51, p < 0.001), QCT Trabecular
(−0.31, p = 0.01) and cortical volumetric BMD and history of cardiovascular events (Mann–Whitney U, p = 0.02). Both
visceral and subcutaneous adipose tissue correlated with BMI (r = 0.63 & 0.64, p < 0.001).
Conclusions: Single CT scan triple assessment of BMD, vascular calcification and body composition is an efficient,
accurate and convenient method of risk factor monitoring post renal transplantation.
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Background
Renal transplantation restores endogenous renal func-
tion in subjects with End Stage Kidney Disease and is
the treatment of choice for suitable patients with renal
failure. However, cardiovascular mortality and fragility
fracture risk remain chronically elevated post renal
transplantation and persisting disturbances in bone min-
eral metabolism are implicated in the genesis of both of
these complications.
The National Kidney Foundation ‘Kidney Disease Out-
comes Quality Initiative’ and other guidelines recom-
mend utilising dual energy x-ray absorptiometry (DXA)
at various intervals post renal transplantation to monitor
bone mineral density [1, 2]. A well-recognized limitation
of this technique of particular concern in renal failure is
the overestimation of lumbar BMD due to the presence
of extraosseous calcification especially overlying aortic
calcification. Alternative methods of assessing bone min-
eral density, such as quantitative CT (QCT) are there-
fore particularly appealing in renal transplant recipients
and have the added advantage of distinguishing between
cortical –which is preferentially influenced by elevated
parathyroid hormone- and trabecular Bone Mineral
Density. The utility of both QCT has been explored in
dialysis dependent populations [3–5] but not in the post
renal transplant setting.
In both the general and renal populations vascular cal-
cification is believed to be a risk marker of cardiovascu-
lar morbidity [6]. A number of non-invasive methods
are available to assess vascular calcification and the
resulting arterial stiffness including plain radiography,
CT assessment of arterial calcification and arterial pulse
wave velocity. Lateral Bone Densitometry has also been
used to assess vertebral BMD and detect vascular calcifi-
cation in hemodialysis [7] and CKD [8] patients. The
KDIGO Clinical Practice Guideline group in 2006 rec-
ommended that lateral abdominal radiography be used
as a screening tool for the detection of vascular calcifica-
tion in patients with CKD Stages 3-5D [9]. A specific
guideline does not exist for the assessment of vascular
calcification in the post-transplant group but surveil-
lance is recommended [10].
While plain radiographs provide a semi-quantitative
anatomical assessment of the presence of vascular calci-
fication and Pulse Wave Velocity provides a functional
assessment of the resultant aortic stiffness, Computed
Tomography provides a more accurate method of quan-
tifying the burden of vascular calcification. Their use is
much enhanced by the now widespread availability of
new generation CT scanners and newer software systems
that can facilitate low radiation dose protocols with ac-
ceptable diagnostic accuracy.
An additional area of increasing research and clinical
interest is the assessment of the change in fat mass post
transplantation and its resulting clinical consequences.
This results in part from the use of immunosuppressive
medications particularly corticosteroids and is poten-
tially associated with insulin resistance, new onset dia-
betes after transplantation and “diabesity” associated
metabolic syndrome and cardiovascular morbidity [11,
12]. Changes in visceral adipose tissue are believed to be
more relevant than changes in subcutaneous adipose tis-
sue but accurate assessment of visceral fat mass is chal-
lenging and difficult to standardize in routine clinical
practice but can be reliably assessed by CT [13–15].
As part of an ongoing prospective cohort study quan-
tifying bone and vascular risk factors in successful renal
transplant recipients (The ABC HeART study) we com-
pared the use of a specifically designed CT protocol, de-
signed to facilitate contemporaneous triple assessment
of lumbar-sacral BMD, aortic calcification and visceral
fat mass with routine clinical measurements.
Methods
ABC HeART is a single centre cohort study of renal
transplant recipients. To be eligible subjects had to be
between 0.5 and 12 years post engraftment of their first
renal transplant, to have an enrollment eGFR > 30 ml/
min/1.73 m2 and to be in their usual state of health. All
study procedures were performed on an outpatient basis.
Informed written consent was obtained from all partici-
pants following approval of the study protocol by the
Clinical Research Ethics Committee of the Cork Teach-
ing Hospitals. Subject demography, clinical details and
past medical, fracture and cardiovascular history were
obtained by patient self-report and abstracted from their
medical records. Weight and height were measured to
calculate Body Mass Index.
Areal Bone Mineral Density was measured at the lum-
bar spine, the femoral neck and proximal femur of both
native hips and the non-dominant forearm, using a
Lunar IDXA scanner (General Electric) and expressed as
both areal Bone Mineral Density and as a T-score. In
keeping with the World Health Organization (WHO)
definition, osteoporosis was defined as a lowest T-score
of −2.5 or less and osteopenia as a T-score of −1.0 to
−2.49, using the Proximal Femur as the reference
standard.
Carotid Femoral Pulse Wave Velocity was performed
by a single investigator (SK) experienced in the perform-
ance of the technique using a dedicated Pulse Trace 400
PWV system (Viasys Healthcare) following the method
described by London [16].
Presence of aortic calcification was assessed by 2 radi-
ologists who were blinded to the clinical study detail.
Aortic vascular calcification was quantified from lateral
lumbar spine radiographs using the Framingham
method, scoring on a scale of 1–3 the presence of
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calcification along the anterior and posterior margin
of the expected aortic contour adjacent to the 4
lumbar vertebrae, resulting in a composite score of
between 0–24 [17].
To facilitate contemporaneous triple assessment of
lumbar BMD, aortic calcification and visceral fat mass a
specifically designed CT protocol was developed. A 64
slice General Electric Medical Systems Lightspeed VCT
XTE scanner was used for evaluation. A helical series
from the L1 to L4 vertebral bodies (modulated 20 to 80
mAs, NI 28, kVp 120) was performed in all patients. An
acquisition slice thickness of 0.625 mm was utilised with
a pitch of 0.984:1, a noise index of 28 (modulated) and a
large field of view. Regular calibration using the BMD
phantom was performed as per manufacturer guidelines.
Bone Mineral Density, aortic calcification and visceral
and subcutaneous fat mass was determined on each CT
scan by 2 radiologists who were blinded to all study
data.
Volumetric cortical and trabecular bone mineral dens-
ity in g/cm3 of the L1 to L3 vertebral bodies was ana-
lysed using the Mindways QCT Pro Bone Mineral
Densitometry System Version 4.2.3, Fig. 1. For trabecular
BMD this also calculates a technique-specific vertebral
T score, expressing the measured BMD in terms of the
number of standard deviations above or below a gender
specific young adult reference population. However,
while this T-score is informative regarding spinal BMD
relative to peak bone mass seen in young adults, it is
neither identical to nor interchangeable with the areal
Fig. 1 Trabecular and Cortical QCT BMD calculation using the Mindways QCT Pro Bone Mineral Densitometry System Version 4.2.3
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BMD T score measured at the proximal femur, as is used
as the reference standard in the WHO definition of
osteoporosis and in the FRAX calculation of estimated
long term fracture risk. The American College of Radi-
ology has recently revised its ‘Practise Parameter for the
performance of Quantitative Computed Tomography
(QCT) Bone Densitometry’ (http://www.acr.org/~/media/
DE78D218C7A64526A821A9E8645AB46D.pdf, accessed
5/09/2015) which provides recommendations on the in-
terpretation of spinal QCT in the absence of femoral mea-
surements. The revised Practise Parameter recommends
using trabecular QCT volumetric BMD cut-offs of <120 g/
cm3 and <80 g/cm3 to estimate the relevant diagnostic
thresholds for osteopenia and osteopenia that equate to
those based on proximal femoral areal BMD measure-
ments. Therefore in addition to the actual measurements
of volumetric BMD, in the case of trabecular bone we also
report both the QCT derived vertebral T-score and the
proportion of subjects meeting the above mentioned
American College of Radiology diagnostic cut-offs.
The extent of arterial calcification in the abdominal
aorta detected by CT was evaluated using 2 standardized
methods [18–20]; a volumetric analysis using threshold
based segmentation (Advantage workstation, GE) and a
semi-quantitative Aortic Calcification Index (ACI) which
involves visual assessment of 12 radial sectors at 10 axial
levels as previously described by Kabaya et al. [18],
Fig. 2. The radial sector based Aortic Calcification Index
(ACI) correlated closely with the volumetric calculation
of aortic calcification (r =0.957, p < 0.001) and as both
methods showed similar associations, for simplicity we
therefore report results using the ACI method only.
The visceral and abdominal wall adipose assessment
was performed using Osirix version 3.7.1. This involves
analysing the fat content (visceral and subcutaneous)
from a single slice, 6 cm above the L4/L5 disc using a
previously validated and published method [15].
Statistical considerations
Data was entered onto a dedicated study database and
summarized using mean and standard deviations (sd) or
medians and intra-quartile range (IQR) as appropriate
for their distribution. Outlying and clinically implausible
values were reconciled against the original clinical record.
Correlations were examined using the non-parametric
Spearman rank method. Hypothesis testing was per-
formed using the Man Whitney U test. Analysis was
conducted using IBM SPSS Statistics version 21
using a 2 sided type one error rate of 0.05.
Results
The baseline clinical characteristics of the 64 study par-
ticipants are shown in Table 1. Age ranged from 18.4 to
74.2 years. All subjects had additional risk factors for
fragility fractures. Two subjects had undergone pre-
emptive transplantation. The median (IQR) duration of
End Stage Kidney Disease was 5.4 years (3.2 -10.0). Ten
subjects (15.6 %) had diabetes; the attributed cause of
ESKD in 6, while it developed post-transplantation in 4.
Six subjects had a past history of atherosclerotic vascular
disease, including 3 who had undergone a coronary re-
vascularization procedure. The majority of subjects were
immunosuppressed using Tacrolimus and Mycopheno-
late Mofetil, with over half having undergone successful
post-transplant corticosteroid withdrawal. The percent-
age of participants with CKD stage 2 T, 3AT, and 3BT
were 36 %, 30 %, 34 % respectively. The majority of sub-
jects had residual post-transplant hyperparathyroidism,
with a median iPTH of 91.5 ng/ml. Six subjects were
treated with vitamin D supplementation and 7 with
Bisphosphonates, of whom 6 meet WHO criteria for
osteopenia and 1 for normal BMD on the basis of their
study femoral hip iDXA scans.
Bone mineral density
Measurements revealed a substantial degree of osteopor-
osis and osteopenia within the study population, Table 2.
In keeping with the high prevalence of hyperparathyr-
oidism, the BMD at the distal radius site - which is pre-
dominantly comprised of cortical bone and thus is
especially susceptible to hyperparathyroidism - was sub-
stantially lower (663 g/cm2) than the proximal femoral
site (946 g/cm2). Mean BMD at the lumbar site was
1163 g/cm2 by IDXA and only 139 g/cm3 by QCT.
These patterns are reflected in the site specific T-scores
measured by the 2 techniques, whereby the distribution
Fig. 2 Calcification assessment using the aortic calcification
index (ACI)
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of T scores for the IDXA lumbar spine was higher than
that of the distal radius or femur or the distribution of T
scores by QCT at the lumbar spine, Fig. 3. The propor-
tion of subjects diagnosed with osteoporosis using the
WHO reference standard of IDXA T score at the prox-
imal femur was 7 %; with site specific osteoporosis rates
of 9 % at lumbar spine and 17 % at the distal radius. The
American College of Radiologists criteria which are
based on volumetric BMD cutoffs classified similar num-
ber of subjects using QCT as by DXA scanning at the
proximal femur as having underlying osteoporosis but
fewer as having underlying osteopenia, Table 2.
The Trabecular QCT volumetric BMD significantly
correlated with areal BMD at the proximal femur (r =
0.68, p < 0.001), lumbar spine (r = 0.61, p < 0.001) and
distal radius (r = 0.32, p = 0.02) but not with QCT mea-
sured cortical volumetric BMD (−0.06, p = 0.7). Cortical
lumbar BMD only correlated significantly with areal
BMD at the lumbar site (r =0.32, p = 0.01) but not at the
distal radius (r =0.22, p = 0.1) or at other sites.
Table 1 Patient clinical characteristics, medication use and laboratory parameters, overall and by the presence of abdominal
calcification
Total ACI Score = 0 ACI Score >0 p-value
(n = 64) (n = 22) (n = 42)
Demographics & Clinical features
Age (years), mean (sd) 47.3 (13.0) 35.8 (8.5) 52.3 (9.6) 0.001
Male: n (%) 39 (61 %) 18 (75 %) 21 (52 %) 0.07
Dialysis Modality: 0.95
Haemodialysis 39 (60.9 %) 15 (62.5 %) 24 (60 %)
Peritoneal dialysis 23 (35.9 %) 8 (33.3 %) 15 (37.5 %)
None (Pre-emptive) 2 (3.2 %) 1 (4.2 %) 1 (2.5 %)
Duration of dialysis (years), 2.3 1.6 3.0 0.03
Median (IQR) (1.6, 3.3) (0.8, 2.0) (1.7, 3.8)
Duration of Transplant (years), 3.7 3.2 4.1 0.40
Median (IQR) (0.9, 8.1) (0.9, 8.8) (0.9, 7.1)
Mean Arterial BP (mm Hg), Mean (sd) 102.7 (9.7) 100.0 (8.8) 104.7 (8.9) 0.01
Body Mass Index (Kg/m2) 25.6 23.7 26.0 0.16
Median (IQR) (22.8, 30.0) (22.1, 29.3) (23.4, 30.1)
Diabetes: N (%) 10 (15.6 %) 3 (12.5 %) 7 (17.5 %) 0.60
Ever Smoked: N (%) 28 (43.8 %) 8 (33.3 %) 20 (50 %) 0.19
Prior parathyroidectomy N (%) 8 (12.5 %) 3 (12.5 %) 5 (12.5 %) 1.0
Past History CV event: N (%) 6 0 6 0.05
Current Medication Use
Tacrolimus: N (%) 56 (87.5 %) 21 (87.5 %) 35 (87.5 %) 1.0
Mycophenolate mofetil: N (%) 52 (81.2 %) 17 (70.8 %) 35 (87.5 %) 0.10
Corticosteroid, N (%) 28 (43.8 %) 10 (41.7 %) 18 (45 %) 0.80
Vitamin D: N (%) 5 1 4 0.64
Laboratory parameters
eGFR (ml/min per1.73 m2) mean (sd) 54.1 (17.6) 57.8 (14.8) 48.3 (14.9) 0.002
iPTH (ng/ml), median (IQR) 91.5 (73,108) 106.5 (83.5, 75.0) 86.5 (57,128) 0.85
Alkaline Phosphatase 106.2 (50.7) 106.5 (38.3) 106.0 (57.3) 0.97
Serum calcium (mmol/L), mean (sd) 2.57 (0.17) 2.52 (0.16) 2.63 (0.17) 0.06
Serum Phosphate (mmol/L), mean (sd) 1.01 (0.22) 1.00 (0.24) 1.02 (0.21) 0.70
Serum Cholesterol (mmol/L), Mean (sd) 4.7 (1.1) 4.2 (0.9) 5.0 (1.0) 0.006
Serum LDL Cholesterol (mmol/L), mean (sd) 2.65 (0.91) 2.34 (0.78) 2.82 (0.94) 0.06
Serum HDL Cholesterol (mmol/L), mean (sd) 1.35 (0.40) 1.28 (0.35) 1.39 (0.42) 0.36
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Vascular calcification
42 patients (64.6 %) had evidence of arterial calcification
on CT. Not unexpectedly, the CT assessment identified
more patients with aortic calcification than plain radiog-
raphy appraisal, which identified 25 patients. Lumbar
radiograph measurement of aortic calcification correlated
closely with Aortic Calcification Index, (r = 0.91, p < 0.001,
Fig. 4). The ACI differed significantly with duration of
dialysis, with mean arterial pressure, hyperlipidaemia,
a history of prior cardiovascular events and with post-
transplant allograft function, Table 1. The ACI
correlated with arterial Pulse Wave Velocity (Pulse Trace
400) (r = 0.29, p = 0.02) and pulse pressure (r = 0.51,
p < 0.001). ACI was negatively correlated with Tra-
becular BMD (r = −0.31, p = 0.01) and positively with
cortical volumetric BMD (r = 0.27, p = 0.03), Table 3.
Fat mass
Body Mass Index Correlated with both Subcutaneous
and Visceral Adipose Tissue volume, (r = 0.66 and r = 0.64
respectively, both p < 0.001). There was no significant
relationship between total cholesterol and any of the CT
Table 2 Areal and volumetric bone mineral density, T scores and diagnosis
Bone Mineral Density T-score Diagnosis
Mean (sd) ra Median (IQR) ra % Osteo-porosis % Osteo-paenia
DXA: Proximal femur 946 g/cm2 (179) 1.0 (ref) −1.2 (−1.8, −0.3) 1.0 (ref) 7 % 53 %
DXA: Neck Of Femur 912 g/cm2 (168) 0.85, P < 0.001 −1.2 (−1.9,-0.4) 0.90 13 % 50 %
P < 0.001
DXA: Distal Radius 663 g/cm2 (119) 0.58, P < 0.001 −1.1 (−2.1,-0.5) 0.45 17 % 43 %
P < 0.001
DXA lumbar Spine 1163 g/cm2 (208) 0.73, p < 0.001 −0.2 (−1.4, 0.7) 0.70 9 % 28 %
P < 0.001
QCT: lumbar, Trabecular 139 g/cm3 (43) 0.68, P < 0.001 −1.2 (−2.4, −0.3) 0.61 9 %b 20%b
P < 0.001
QCT: Lumbar, Cortical 469 g/cm3 (32) 0.18, P = 0.17 n/a n/a n/a n/a
QCT: Lumbar Total 606 g/cm3 (50) 0.65, P < 0.001 n/a n/a n/a n/a
a Correlation using Spearman rank method
bUsing American College of Radiology cutoffs of QCT trabecular BMD <80 g/cm3 as being suggestive of osteoporosis and 80–120 g/cm3 as being suggestive
of osteopenia
Fig. 3 Boxplot showing median (solid line) and intra-quartile range (box) of IDXA measured areal Bone Mineral Density by site and QCT measured
volumetric Bone Mineral Density at the lumbar spine
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measures of adiposity. Triglyceride level correlated
with Visceral Adipose Tissue volume (VAT) (r = 0.43,
p < 0.001), but not with Subcutaneous Adipose Tissue
(SAT) volume. HDL level did not correlate with either
VAT or SAT, however VAT did correlate negatively
with LDL, although the relationship was weak, (r =
−0.27, p = 0.05).
Convenience
Acquisition time for each CT was equivalent to a stand-
ard CT lumbar spine with a patient time slot of 10 mi-
nutes each. The average time for analysis per patient was
3.5 minutes for BMD assessment (including cortical and
trabecular), 2.1 minutes for fat appraisal and 5.6 min to
complete both methods of calcium evaluation.
Safety
The estimated effective radiation dose in this population
was 2.4 mSv (range 2.0 – 2.7 mSv) per study, as calcu-
lated using the ImPACT CT Dosimetry tool (GE Health-
care). This compares to quoted effective radiation doses
of 1.0 mSv for standard AP and lateral radiograph of
lumbar spine [21].
Discussion
The comprehensive ‘triple assessment’ of the evaluated
patient cohort in this study using a single CT scan high-
lights the important clinical information that can be ob-
tained in a manner that is efficient and convenient for
both the patient and staff.
From the patient viewpoint it involves a single CT that
takes less than ten minutes and which does not require
preparation and does not involve contrast
administration.
Fracture risk is elevated in Chronic Kidney Disease
and End Stage Kidney Disease and the risk of fracture
further increases post transplantation. The cumulative
incidence of any fracture post transplantation is reported
to be as high as 60 % [22] and is accompanied by an in-
creased risk in all-cause mortality compared to fractures
in the general population [23]. The pathogenesis of fra-
gility fractures in CKD is more complicated than in the
general population due to presence of underlying quali-
tative abnormalities of bone. This has resulted in recom-
mendations against the routine use of bone density
measurement in patients on dialysis, but with the restor-
ation of endogenous renal function post transplantation
current guidelines support the resumption of DXA
screening.
The examination of spinal areal BMD by DXA is sub-
ject to several well recognized limitations, as the trad-
ition posterior-anterior approach of DXA scanning
cannot distinguish between calcification within the ver-
tebrae and the extra-osseous structures such as osteo-
phytes, osteochondrosis or –of special relevance in
CKD- within the calcified wall of the abdominal aorta.
Although the vertebral body is predominantly comprised
of trabecular bone, the DXA measurement is a compos-
ite of both vertebral cortical and trabecular bone and is
heavily influenced by the calcium content of the cortical
bone that comprises the posterior elements of the verte-
brae which contributes relatively little to the integrity of
the vertebral body. Thus the DXA derived areal BMD
lumbar T score is typically substantially higher than that
Fig. 4 Scatterplot of the relationship between Lumbar Radiograph Measurement of Calcification and CT Determined Aortic Calcification Index
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Table 3




QCT Trabecular QCT Cortical
Age (years) 1 −0.43
(p < 001)
0.15 (p = 0.9) 0.30 (p = 0.02) 0.41 (p < 001) 0.19 (p = 0.14) 0.72
(p < 001)




−0.43 (p < 0.001) 1 −0.16 (p = 0.2) −0.34 (p < 0.01) −0.37 (p < 0.01) 0.09 (p = 0.5) −0.31
(p = 0.01)
−0.25 (p = 0.06) 0.09 (p = 0.5) 0.09 (p = 0.5) −0.12 (p = 0.3)
iPTH
(ng/ml)
0.15 (p = 0.9) −0.16
(p = 0.2)
1 0.07(p = 0.6) −0.08 (p = 0.5) 0.01 (p = 0.9) −0.01
(p = 0.9)
−0.12 (p = 0.4) −0.04 (p = 0.8) 0.10 (p = 0.5) −0.29 (p = 0.02)
MAP
(mm Hg)
0.29 (p = 0.2) −0.34
(p < 0.01)
0.07 (p = 0.6) 1 0.59 (p < 0.001) 0.07 (p = 0.6) 0.42
(p < 0.001)




0.41 (p = 0.001) −0.37
(p < 0.01)
−0.08 (p = 0.5) 0.59 (p < 0.001) 1 0.02 (p = 0.9) 0.51
(p < 0.001)





0.19 (p = 0.14) 0.09
(p = 0.5)
0.01 (p = 0.9) 0.07 (p = 0.6) 0.02 (p = 0.9) 1 0.29
(p = 0.02)
0.28 (p = 0.04) 0.32 (p = 0.01) 0.17 (p = 0.2) 0.30 (p = 0.02)
ACI 0.72 (p < 0.001) −0.31
(p = 0.01)




0.67 (p < 0.001) −0.25
(p = 0.06)
−0.12 (p = 0.4) 0.40 (p < 0.01) 0.46 (p < 0.001) 0.28 (p = 0.04) 0.91
(p < 0.001)





−0.17 (p = 0.2) 0.09
(p = 0.5)
−0.04 (p = 0.8) −0.33 (p = 0.01) −0.16 (p = 0.2) 0.32 (p = 0.01) −0.19
(p = 0.15)




−0.38 (p = 0.002) 0.09
(p = 0.5)
0.10 (p = 0.5) −0.21 (p = 0.09) −0.15 (p = 0.3) 0.17 (p = 0.2) −0.31
(p = 0.01)
−0.28 (p = 0.03) 0.68 (p < 0.001) 1 −0.07 (p = 0.6)
QCT Cortical
BMD (g/cm3)
0.34 (p = 0.006) −0.12
(p = 0.3)
−0.29 (p = 0.02) −0.16 (p = 0.2) −0.02 (p = 0.9) 0.30 (p = 0.02) 0.27
(p = 0.03)
0.19 (p = 0.15) 0.18(p = 0.17) −0.07 (p = 0.6) 1












measured at other sites as is also evident from our re-
sults as shown in Fig. 3. QCT by measuring a true volu-
metric BMD of the trabecular bone specific at the site at
which the vertebral collapse occurs is able to avoid these
limitations. The calculation of a QCT derived lumbar
trabecular T score helps highlight the often extensive re-
duction in vertebral BMD as compared to the BMD of
gender changed young adults and allows for inter-
subject comparisons. This score however is not repre-
sentative of the T-score that would be obtained using ei-
ther a QCT or DXA at the proximal femur, as is the
reference standard for the WHO diagnosis of osteopor-
osis and which is used in the FRAX calculation of long
term fracture risk. Instead The American College of Radi-
ology recommends cutoffs based on reduced volumetric
BMD that are intended to replicate the diagnosis of under-
lying osteoporosis and osteopenia as would be obtained
using the reference standard of femoral BMD. In our ana-
lysis the application of these cutoff resulted in similar
identification of subjects with osteoporosis but the identi-
fication of substantially fewer subjects with osteopenia.
The FDA has recently approved additional novel tech-
niques in QCT that allow for the direct measurement of
femoral areal BMD as is used as the reference standard in
the diagnosis of osteoporosis and which can be obtained
at the same time as measuring lumbar volumetric BMD.
The separate measurement of cortical and trabecular
volumetric BMD is of special relevance in renal allograft
recipients with persistent or progressive residual hyper-
parathyroidism, as this preferentially induces cortical
bone loss, the impact of which can be seen in the mea-
sured areal BMD at the distal radius which is almost ex-
clusively comprised of cortical bone and which
demonstrates the lowest T score of all sites examined in
our study and which moreover significantly correlates
with the post-transplant iPTH level. In addition, as tra-
becular bone is more metabolically active than cortical
bone, it responds more rapidly to either a change in
bone turnover or to therapeutic interventions. Thus the
specific measurement of trabecular volumetric BMD as
well as indicating the risk of spinal collapse fracture and
facilitating the diagnosis of osteoporosis, allows for more
rapid assessment of the impact of a change in treatment
or clinical circumstance. The fact that the two different
forms of bone differ in their susceptibility and response
to insults, and as in our study there was no correlation
between QCT measured trabecular and cortical bone
mineral density further underscores the rationale for
their separate evaluation rather than the use of a
composite measure. While the optimal treatment of
osteoporosis post transplantation is unclear, accurate
quantification of the severity of the bone mineral deficit
and its change over time should inform any discussion
of the potential risks and benefits of any proposed
intervention. Furthermore the reliable early identifica-
tion of decreased bone mineral density at least facilitates
secondary risk reduction such as the selective applica-
tion of corticosteroid minimization or avoidance; strat-
egies that are beneficial to the bone but which are not
devoid of risk to the allograft.
Vascular calcification is proposed to be a major driving
force in increased cardiac afterload and heart failure in
ESKD populations. Plain radiography is a useful non-
invasive and inexpensive tool for detecting the presence
of vascular calcification, both in the general population
and in CKD. Kauppila at al introduced a semi-
quantitative scoring system for vascular calcification
using lateral radiographs of the lumbar spine. This scor-
ing system was used in a study of 515 dialysis patients
which showed the presence of aortic calcification to be
predictive of all cause and cardiovascular mortality [24].
Carotid – Femoral (Aortic) Pulse Wave Velocity mea-
sures the speed with which the arterial pulse travels
down the aorta and thus is a functional measure of aor-
tic stiffness. It is inexpensive to perform and an inde-
pendent predictor of cardiovascular mortality, [25]
including in ESKD [26].
The technique is however very user dependent and
subject to considerable inter-individual variability. The
accurate assessment of vascular calcification should sup-
port aggressive cardiovascular risk reduction as well as
potentially supporting prospective monitoring of cardiac
function, while in a research setting it should facilitate a
better understanding of the natural history and patho-
physiology of vascular calcification post transplantation.
The pathogenic consequences of alterations in visceral
fat mass post transplant is unclear and is a subject of
substantial ongoing research. One limitation to exploring
these relationships is the difficulty in accurately measur-
ing visceral fat mass using routine clincal measures.
While fat mass correlates with hip-waste circumference,
such measures are often inaccurate and lack precision.
The assessment of fat mass using single slice CT has
been validated [14] and has been shown to be associated
with the metabolic syndrome [27, 28] and increased car-
diovascular risk [29]. Thus fat mass assessment as part
of the triple assessment may further enhance cardiovas-
cular risk factor stratification and should provide consid-
erable research opportunitiues in the evaluation of this
pathophysiological process.
Increasing attention has focused in recent times on
the potential deleterious effects of cumulative radiation
exposure. We were able to undertake the CT triple as-
sessment using a protocol which imparts a radiation ex-
posure approximately 2.5 times that of the standard
lateral lumbosacral x-ray that is recommended by
KDIGO . The increased precision and accuracy of CT
assessment may result in a reduced number of studies
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especially in those patients who can be reliably shown to
be free of calcification post engraftment. This incremen-
tal radiation exposure is further offset if the analysis is
conducted as part of a CT scan that is otherwise sched-
uled for clinical reasons.
The potential cost implications of the proposed CT
evaluation depends heavily on the local medical infra-
structure and reimbursement environment. The applica-
tion requires the presence of an appropriate CT service
with sufficient scheduling flexibility as to allow for the
additional study time of undertaking the QCT. The costs
of the specific QCT software package and phantom for
calculation of volumetric BMD would be expected to be
less than that of the purchase of an entry level DXA
scanner - assuming the presence of an existing CT ser-
vice. From a staff viewpoint the time commitment to
perform either the CT scan or the iDXA are similar, as
are the approximate time requirements for reading the
scans. Of note in Australia the measurement of volumet-
ric BMD by QCT is reimbursed at the same rate as that
of areal BMD by DXA. The CT has the additional cost
effective element of providing additional information on
the intra-abdominal structures avoiding the need for
separately conducted imaging studies.
Limitations of our study are its limited sample size
and that it is based in a single Irish institution. Within
the current study we did not examine the inter or intra
individual reproducibility of the techniques used, how-
ever, at least in the case of the assessment of aortic calci-
fication the proposed technique would be expected to be
less subjective than the existing approach using lateral
lumbar x-rays. Additionally, due to the cross-sectional
nature of our analysis, the accuracy of CT based mea-
sures of Bone Mineral Density, aortic calcification and
adiposity in predicting fracture occurrence and cardio-
vascular events in the renal transplant population could
not be determined. Follow-up of these outcomes over
time may help clarify these issues.
Conclusion
We demonstrate the feasibility of conducting accurate
simultaneous assessment of lumbar Bone Mineral Dens-
ity, aortic calcification and visceral fat mass using a spe-
cifically designed single CT protocol. This single CT
scan offers a “one stop shop” approach to measuring
these important indices. The resulting data is likely to be
considerably more accurate than that obtained by
methods currently in routine clinical use. The precise
role and long term attributable benefit of this technique
requires confirmation. However the above approach may
be of substantial utility in a research setting and should
be considered at least where repeated radiographic as-
sessment of vascular calcification is planned as part of
routine clinical practice.
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